At ZOIA Pharma, we understand the critical role of medical foods tailored to individuals living with inherited metabolic disorders and other rare diseases. These conditions require more than just conventional food—they necessitate specialized solutions that cater to unique nutritional needs as defined by the U.S. Food and Drug Administration (FDA)¹.
Medical foods are not ordinary. They are formulated and designed to meet specific dietary requirements that cannot be satisfied through regular diet alone and their nutrients, ingredients and proportions are individualized to each patient. These products often are available as powders, liquids and bars and can be used only under medical supervision¹, forming the cornerstone of a comprehensive management plan for various conditions or diseases.
ZOIA Pharma supplies an extensive portfolio of medical foods and is the exclusive U.S. distributor of PKU GOLIKE, the first prolonged-release phenylalanine (Phe)-free product for the dietary management of both children and adults. This ground-breaking formula addresses common complaints about medical foods, such as unpleasant flavor, aftertaste and bad breath. Our services go beyond providing these important foods to include navigating the complexity of insurance coverage, product distribution and clinical support.
Our partnership with the rare disease community underscores our dedication to improving the quality of life for individuals requiring medical foods. By broadening access to a comprehensive range of medical food options, ZOIA Pharma strives to empower patients and their families to manage inherited metabolic disorders more effectively.
